Literature DB >> 23518314

Alterations in molecular status of plasma fibronectin associated with aging of normal human individuals.

Anna Lemańska-Perek1, Małgorzata Pupek, Bożena Polańska, Jerzy Leszek, Iwona Kątnik-Prastowska.   

Abstract

OBJECTIVES: Senescence, progressive deterioration of many bodily functions might be associated with age-dependent alterations of plasma fibronectin (FN) molecular status (i.e., domain, glycotope, and molecular form expressions). DESIGN AND METHODS: FN molecular status was analyzed in 127 plasma samples of healthy individuals in groups of newborns, and subjects aged 3-14, 15-39, 41-59, and 60-82 years by FN-ELISA, lectin-FN-ELISA, and immunoblotting using a set of domain-specific monoclonal antibodies, specific lectins, and monoclonal antibody to FN, respectively.
RESULTS: During the first four decades of human life the levels of cell-binding-, carboxyl-terminal-, collagen-, heparin-, and fibrin-domains of plasma FN gradually increased. In subjects aged up to 82 years the cell-binding and carboxyl-terminal FN domain concentrations did not change, while the heparin, fibrin, and collagen domains significantly increased. The relative reactivity of plasma FN with Maackia amurensis lectin, specific to α2,3-linked sialic acid, significantly decreased after birth, reaching a stable level in the subsequent life period, whereas with Sambucus nigra lectin, specific to α2,6-linked sialic acid, it significantly decreased in the 60-82 year old group. Moreover, the appearance of 280-kDa and 320-kDa FN bands, absent in young and mature healthy individuals, was found in the groups of 41-59 and 60-82 year olds.
CONCLUSIONS: The alterations of FN molecular status throughout growth, maturation and senescence might be associated not only with disturbances in the balance of FN production rate and degradation, but concomitantly with conformational rearrangements of FN and its engagement in age-related vascular remodeling processes.
Copyright © 2013 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23518314     DOI: 10.1016/j.clinbiochem.2013.03.008

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  8 in total

1.  Serum fibronectin levels in acute and chronic viral hepatitis patients.

Authors:  Ayse Erturk; Erkan Cure; Zulal Ozkurt; Emine Parlak; Medine Cumhur Cure
Journal:  Malays J Med Sci       Date:  2014-01

2.  Time-dependent changes in extra-domain A-fibronectin concentration and relative amounts of fibronectin-fibrin complexes in plasma of patients with peripheral arterial disease after endovascular revascularisation.

Authors:  Małgorzata Pupek; Dorota Krzyżanowska-Gołąb; Daniel Kotschy; Wojciech Witkiewicz; Wiesława Kwiatkowska; Maria Kotschy; Iwona Kątnik-Prastowska
Journal:  Int Wound J       Date:  2018-03-13       Impact factor: 3.315

3.  Fibronectin as a Marker of Disease Severity in Critically Ill COVID-19 Patients.

Authors:  Anna Lemańska-Perek; Dorota Krzyżanowska-Gołąb; Barbara Dragan; Maciej Tyszko; Barbara Adamik
Journal:  Cells       Date:  2022-05-06       Impact factor: 7.666

4.  Comparative Analysis of the Extracellular Matrix Composition in Proliferating and Involuted Infantile Hemangiomas.

Authors:  Hyochun Park; Hannara Park; Ho Yun Chung; Teresa M O; Milton Waner
Journal:  Arch Plast Surg       Date:  2015-09-15

5.  Explainable Artificial Intelligence Helps in Understanding the Effect of Fibronectin on Survival of Sepsis.

Authors:  Anna Lemańska-Perek; Dorota Krzyżanowska-Gołąb; Katarzyna Kobylińska; Przemysław Biecek; Tomasz Skalec; Maciej Tyszko; Waldemar Gozdzik; Barbara Adamik
Journal:  Cells       Date:  2022-08-05       Impact factor: 7.666

6.  Analysis of Soluble Molecular Fibronectin-Fibrin Complexes and EDA-Fibronectin Concentration in Plasma of Patients with Atherosclerosis.

Authors:  Anna Lemańska-Perek; Dorota Krzyżanowska-Gołąb; Małgorzata Pupek; Piotr Klimeczek; Wojciech Witkiewicz; Iwona Kątnik-Prastowska
Journal:  Inflammation       Date:  2016-06       Impact factor: 4.092

Review 7.  Angiogenesis, Cancer, and Vascular Aging.

Authors:  Junji Moriya; Tohru Minamino
Journal:  Front Cardiovasc Med       Date:  2017-10-24

8.  Plasma and Cellular Forms of Fibronectin as Prognostic Markers in Sepsis.

Authors:  Anna Lemańska-Perek; Dorota Krzyżanowska-Gołąb; Tomasz Skalec; Barbara Adamik
Journal:  Mediators Inflamm       Date:  2020-08-01       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.